Carregant...
A novel anti-IL4Rα nanoparticle efficiently controls lung inflammation during asthma
Drug resistance and the harmful side effects accompanying the prolonged corticosteroid treatment of chronic pulmonary diseases prompted the development of more specific anti-inflammatory approaches. Several strategies aiming to block IL4Rα, the receptor for a key pro-inflammatory pathway, were inves...
Guardat en:
| Publicat a: | Exp Mol Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099422/ https://ncbi.nlm.nih.gov/pubmed/27713399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2016.89 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|